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Nanomedicine utilizes biocompatible nanomaterials for therapeutic purposes to treat various diseases.
Flavonoids present in the plant materials act as both reducing and electrostatic stabilizing agents for
the ‘Green’ synthesis of metal nanomaterials. Further, these nanomaterials are effectively used to treat
various cancer cells and pathogenic microbes. The experimental approach for flavonoids-mediated nano-
material (FMN) synthesis is simple, rapid, cost-effective and reproducible. However, the detailed reports
on synthesis, mechanism, and in vivo application of FMN are very limited in literatures. Thus, this focused
review will definitely help researchers who are working on biocompatible nanomaterial synthesis and
application in biomedical sector. Further, this is the first review to discuss the significance, mechanisms,
and future trends of FMN. The FMN and their dual function as both nano-carrier and nano-drug in various
biomedical sectors might be a hot research topic in upcoming days.
 2017 Published by Elsevier B.V.1. Introduction
Metal nanomaterials are known to have immense applications
in the field of agriculture, energy, environment, and medicine [1].
Different kinds of physical, chemical, and biological methods have
been reported for the synthesis of metal nanomaterials [2–6].
Metal nanomaterials are highly biocompatible and possess various
pharmacological activities. Thus, biosynthesis and characterization
of metal nanomaterials are in limelight till date [7]. Interestingly,
plant based ‘Green’ synthesis of nanomaterials has drawn great
attention due to its cost-effective, eco-friendly, non-pathogenic,
rapid, and also efficiency in the treatment process. In addition,
‘‘Green” synthesis provides a single step technique as well as
trouble-free to scale up for large synthesis.2. Plant based metal nanomaterials
Since ancient times, plants have been used as natural remedies
for curing many physiological disorders in traditional easternmedicine, particularly Indian and Chinese. The ‘Green’ synthesis
of copper (Cu), gold (Au), nickel (Ni), platinum (Pt), titanium (Ti),
selenium (Se), silver (Ag), and zinc nanoparticles (ZiNPs) using
plant resources had been previously reported in literatures [8].
The plant based metal nanoparticles (MNPs) showed excellent
antimicrobial, anticancer, antidiabetic, anti-inflammatory, antioxi-
dant, and immunomodulatory activities [9,10]. Recently, Ahmad
et al. [11], Ovais et al. [12], and Kuppusamy et al. [8] reviewed
the synthesis of MNPs using different plant extract. Most of the
previous reports confirm that the presence of phytochemicals such
as alkaloids, flavonoids, phenols, terpenoids, alcohols, sugars, and
proteins in the plant materials are involved in the reduction and
stabilization of metal ions [13,14]. Although, the synthesis of MNPs
using a single active substance from plant extract will be helpful
for the purification of nanoparticles, and further study on such
MNPs in biomedical sector is needed to treat specific diseases. At
present, there is little information available in literature about a
single substance from plant extract to synthesis MNPs. Recent
reports highlighted the fact that flavonoids widely existing in the
plant extract contributing a major role in the bioreduction of metal
ionic into nanoparticle formation [5,15].
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Flavonoids, a large class of secondary plant metabolites, are uti-
lized for human health care due to their biological and pharmaco-
logical activities [16]. They share a common carbon skeleton of two
benzene rings joined by a 3-carbon bridge (C6-C3-C6), as shown in
Fig. 1. The subclasses of flavonoids mentioned are anthocyanidins,
flavonols, flavones, flavanones, and isoflavones [17]. Flavonoids are
used to treat many pathological conditions including Alzheimer’s
disease, cancer, cardiovascular disorder, microbial infection,
inflammatory disease, oxidative-nitrosative stress, atherosclerosis,
neurodegenerative disease, and macrophage oxidation [18]. In par-
ticular, the flavonoids showed very less or no cytotoxic effect on
healthy cells, while being cytotoxic against various cancer cells
[19]. Apart from this, Martirosyan et al. [20] proved the protective
effects of flavanoid against the cytotoxicity and oxidative stress
triggered by AgNPs in normal cells. Therefore, flavonoids-
mediated nanomaterial (FMN) might be a bioactive therapeutic
tool to treat various diseases (Fig. 2), and also considered as an
alternative to the immunosuppressive agents.4. FMN and their biomedical efficacy
Table 1 illustrates the detail of flavonoids involved in the MNPs
synthesis and their biomedical efficacy. Recently, our group found
the total flavonoids present in the Alternanthera tenella and Corian-
drum sativum leaf extracts majorly involved in AgNPs synthesis;Fig. 1. Basic chemical structure of flavonoid.
Fig. 2. Flavonoids-mediated nanomaterial (FMand showed antiacne, antidandruff, and antibreast cancer efficacy
against Propionibacterium acnes, Malassezia furfur, and human
breast adenocarcinoma cells, respectively [5,15]. Zuas et al. [21]
reported that the water soluble flavonoids present in Myrmecodia
pendan extract were mainly responsible for the reduction process
of Ag+ to AgNPs. The flavonoids of Dalbergia spinosa leaf extract
could be adsorbed onto the metal surface by interacting with car-
bonyl groups or electrons, and exhibited enhanced anti-
inflammatory, and antibacterial (against Bacillus subtilis, Pseu-
domonas aeruginosa, Staphylococcus aureus, and Escherichia coli)
activities [22]. Raghunandan et al. [23] noticed that flavonoids
functionalized clove buds extract derived AuNPs showed anti-
cancer activity against various cancer cells.
Aromal and Philip [24] carried out the synthesis of AuNPs using
Trigonella foenum-graecum seed extract and concluded that flavo-
noids are powerful reducing agents for chloroauric acid (HAuCl4)
reduction. The flavonoids in the aqueous extract of Ranunculus
muricatus interact with metal ions through coordinate covalent
bond for Au/TiO2 nanocomposite formation, and further it effec-
tively inhibits S. aureus and E. coli [25].
Apigenin is citrus bioflavonoid, which possess antioxidant, anti-
inflammatory, and anticancer activities. Kasthuri et al. [26] synthe-
sised AuNPs and AgNPs using apiin (apigenin glycoside) extracted
from Lawsonia inermis and expected to be an effective nano-drug to
treat cancer.
Baicalein is the major bioactive flavanoid, which exhibits
remarkable synergetic effects with tetracycline and b-lactams in
the treatment of methicillin-resistant S. aureus. Furthermore, bai-
calein has been reported to attenuate the quorum sensing-
controlled virulence factors including biofilm formation in P. aerug-
inosa [27]. Rajkumari et al. [28] reported the synthesis of baicalein
mediated AuNPs, and confirmed their enhanced antibiofilm activ-
ity against opportunistic pathogen, P. aeruginosa compared to
baicalein.
Dihydromyricetin (DMY) is a type of flavonol. It has multiple
biological effects including hypoglycemic, antioxidant, and
antibacterial activities [29,30]. Guo et al. [31] synthesised AuNPs
using DMY without adding any external surfactant, capping agent
or template. Furthermore, the experimental approach suggests that
the flavonoid mediated AuNPs synthesis is simple, rapid, cost-
effective, and reproducible.
Genistein, a naturally occurring isoflavonoid has anticancer
and antiangiogenic properties [32]. Most recently, Stolarczyk
et al. [33] observed that genistein reduces Au3+to spherical Au0N) synthesis and biomedical applications.
Table 1
Mechanism and biomedical applications of FMN.
S. No. Flavonoids Nanomaterials Mechanism Biomedical applications References
1 Apiin (Apigenin
glycoside)
AuNPs (21 nm)
AgNPs (39 nm)
Metal ions are reduced with the hydroxyl groups
of the apiin and further oxidized to carbonyl
groups. The carbonyl groups bind to metal ion
and form apiin coat on nanoparticles.
Anticancer activity [26]
2 Baicalein AuNPs (26.5 nm) – Antibiofilm activity against P. aeruginosa [28]
3 Catechin c-SiNPs – Enhanced protective activity against oxidative
stress and hippocampal cell survival
[40]
4 Dihydromyricetin AuNPs Hydroxyl groups involved in the reduction
process
– [31]
5 Epicatechin &
Theaflavin
AgNPs (31 nm) Carbonyl groups participated in the
bioreduction of AgNO3 and AgNPs stabilization.
Anticancer activity against human epidermoid
larynx carcinoma cells
[41]
6 Flavonoids
(Dalbergia spinosa)
AgNPs (18 nm) Adsorbed onto the metal surface by interacting
with carbonyl groups or electrons.
Anti-inflammatory & antibacterial (E. coli, P.
aeruginosa, S. aureus, and B. subtilis) activities
[22]
7 Flavonoids
(Ranunculus
muricatus)
Au/TiO2 Hydroxyl groups of flavonoids interact with
metal ions through covalent bond.
Antibacterial activity against S. aureus and E. coli [25]
8 Flavonoids
(Coriandrum
sativum)
AgNPs (37 nm) – Antiacne (P. acnes), antidandruff (M. furfur) &
anticancer (human breast cancer) activities
[5]
9 Flavonoids
(Tephrosia
tinctoria)
AgNPs (h1 0 0 nm) – Antidiabetic activity [42]
10 Flavonoids
(Potentilla fulgens)
AgNPs (10–15 nm) – Anticancer (human breast cancer and human
glioblastoma cancer cells) and antibacterial
(E. coli and B. subtilis) activities.
[43]
11 Flavonoids
(Andean
blackberry)
AgNPs (12–50 nm) Hydroxyl and carbonyl groups of flavonoid were
adsorbed on the surface of AgNPs and involved
in the reduction process.
Antioxidant activity [46]
12 Flavonoids
functionalized
clove buds
AuNPs & AgNPs – Anticancer activities against four cancers: (i)
human cervix, (ii) human chronic myelogenous,
(iii) human colorectal adenocarcinoma, bone
marrow and leukemia, and (iv) human kidney
cancer cell.
[23]
13 Genistein AuNPs (64.64 nm) The electron transfer from genistein into the Au
center and reduced Au3+to Au0. Further acted as
a stabilizing agent to form a layer of negative
ions converting the surface of the AuNPs.
Anticancer activities against human epithelial
lung carcinoma and human melanoma cells.
[33]
14 Kaempferol AuNPs (16.5 nm) Hydroxyl groups in the B and C rings of
kaempferol involved in the k-AuNPs formation.
The A ring of k-AuNPs participated in radical
scavenging activity
Anticancer activity against human breast cancer. [34]
15 Luteolin
(Coriandrum
sativum)
AgNPs (13 nm) Enol form of luteolin freely liberates reactive
hydrogen and converts Ag+ to Ag0.
Antimicrobial activity against B. subtilus [44]
16 Proanthocyanidin AuNPs
(17–29 nm)
– Efficient cardio-protective potential with good
biocompatibility.
[36]
17 Proanthocyanidin
& Flavonol
glycosides
AgNPs (20–80 nm) – – [37]
18 Quercetin Ag-SeNPs
(30–35 nm)
– Antioxidant, antimicrobial, and anticancer
activities.
[39]
19 Quercetin Metal
nanoparticles
Chelate at three positions involving the carbonyl
and hydroxyl groups at the C3 and C5 positions
and the catechol group at the C30 and C40 site.
These groups chelate metal ions.
– [45]
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ing high cytotoxic activity against human melanoma cells.
Kaempferol, a flavonol is present in a variety of plant sources.
Raghavan et al. [34] reported that the kaempferol participated in
the formation of AuNPs, and showed promising anticancer activity
against human breast cancer.
Proanthocyanidin (PAC) possesses antiviral, antiallergic, and
vasodilatory activities [35]. Vinodhini et al. [36] synthesised PAC
mediated AuNPs, which showed efficient cardio-protective poten-
tial with good biocompatibility. Kumar et al. [37] reported that PAC
and flavonol glycosides present in the capuli cherry were mediated
the AgNPs synthesis.
Quercetin can scavenge free radicals that generated by metals
[38]. Mittal et al. [39] proved quercetin is mainly responsible for
the reduction and stabilization of metal ions. Interestingly, thestudy confirmed quercetin mediated bimetallic Ag-SeNPs possess
higher therapeutic efficacy in terms of antioxidant, antimicrobial,
and anticancer activities.
The flavonoid catechin has been used to treat neurodegenera-
tive diseases. Therefore, Halevas et al. [40] fabricated hybrid
catechin-silica nanoparticle (c-SiNPs) and confirmed their efficient
protectant effects against neuronal cell loss. Satyavani et al. [41]
noticed that epicatechin and theaflavin present in the calli cells
of Citrullus colocynthis are play a crucial role in the bioreduction
of Ag+ to AgNPs, and their stabilization.
Rajaram et al. [42] synthesised AgNPs using Tephrosia tinctoria
and its antidiabetic activity was assessed. Further, the study con-
firmed enhanced bioactivity of AgNPs due to the attachment of
phenol and flavonoid compounds. The flavonoid content in Poten-
tilla fulgens mediated AgNPs was fourfold higher than phenolic,
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This AgNPs effectively inhibited the human glioblastoma cancer
cells, and also the opportunistic pathogenic microbes such as
E. coli and B. subtilis [43]. However, none of the study carried out
to state the efficacy of FMN for in vivo biomedical applications.
Thus, further studies needed to compare the pharmacological effi-
cacy of individual flavanoid and its mediated MNPs to know their
accurate biomedical functions.5. Mechanism of nanomaterial formation by flavonoids
Few studies have proposed the possible mechanism for flavo-
noids interaction with metal ions to nanomaterial formation
(Table 1). According to Raghavan et al. [34], the hydroxyl groups
present in the B and C rings of kaempferol may participate in the
AuNPs formation. Further, the A ring of kaempferol coated on the
surface of AuNPs may be responsible for the radical scavenging
activity. Nazeruddin et al. [44] reported the formation of enol form
of the luteolin which freely liberates reactive hydrogen, is respon-
sible for the conversion of Ag+ to Ag0.
Guo et al. [31] reported the formation of AuNPs by DMY
through the oxidation of hydroxyl to carbonyl groups. The study
found that the stretching vibration of DMY hydroxy groups shifted
to higher wavenumber after bioreduction, which indicated that
hydroxy groups participated in the reaction. In addition, the
stretching vibration of carbonyl groups shifted to lower wavenum-
ber due to the oxidation of hydroxyl groups and the formation of
intramolecular hydrogen bonds.
Quercetin can chelate at three positions involving the carbonyl
and hydroxyl groups at the C3 and C5 positions and the catechol
group at the C30 and C40 site. These groups chelate different metal
ions by the following steps: (i) adsorbed onto the metal surface, (ii)
budding of nanoparticle, (iii) aggregation, and (iv) bioreduction
[45]. Stolarczyk et al. [33] proposed the mechanism for genistein-
AuNPs complex formation as follows: (i) the electron transfer from
genistein into the Au center, (ii) the genistein reduced Au3+ to Au0,
and (iii) further acted as a stabilizing agent to form a layer of neg-
ative ions converting the surface of the AuNPs.
Kumar et al. [46] observed the hydroxyl and carbonyl groups of
flavonoids present in the Andean blackberry fruit extract were
adsorbed on the surface of AgNPs and involved in the reduction
process. Kasthuri et al. [26] revealed that Au3+/Ag+ions were
reduced by hydroxyl groups of the apiin, and the hydroxyl groups
were further oxidized to carbonyl groups. Then, the carbonyl
groups of apiin bind to metal ion and form over coating on the
nanoparticles to prevent gathering. Most of these available litera-
tures clearly suggest that both hydroxyl and carbonyl groups pre-
sent in the flavonoids are collectively playing a major role in the
formation of FMN (Fig. 2). To conclude, the efficiency of nanomate-
rial formation by flavonoids depends on the number of hydroxyl
group and carbonyl group in the ‘A’, ‘C’, and ‘B’ rings of the flavo-
noid structure. The chemical modification of hydroxyl and car-
bonyl groups may provide insight into the importance of number
and positioning of these groups in the formation of nanomaterials.6. Dual function of FMN to treat various diseases
As mentioned above, flavonoids find a wide range of applica-
tions. However, flavonoids impede their bioactivity in vivo applica-
tions, due to their low absorption, poor stability, insolubility,
passive diffusion, and active efflux in the gastrointestinal (GI) tract
[47]. Interestingly, novel drug delivery system using nanomaterials
with a broad spectrum of applications offer a new therapeutic base
for scientific integration and innovation. Recent literatures proved
that metal based nanomaterials are acting as both nano-carrier andnano-drug for various routes of administration as well as rapid
recognition by the immune system [28,33]. In these flavonoids-
nanoparticles complex, nanoparticles interact with flavonoids via
hydrogen bonds and hydrophobic interactions which can enhance
aqueous solubility of flavonoids at target sites. Importantly,
nanoparticles may protect flavonoids against decomposition pro-
cess occurring in the GI, and further nanoparticles can be taken
directly up by epithelial cells in small intestine, which significantly
increases absorption and bioavailability of flavonoids [48].
Nanoparticles are established with hydrophobic groups inside
and polar groups on surface of particles. For example, Zou et al.
[49] achieved encapsulation of procyanidin into zein nanoparticles
and observed increased procyanidin solubility in aqueous system.
MNPs synthesised by different methods have been used as a
nano-carrier for flavanoid delivery. Hsieh et al. [50] studied the
physical attachment of epigallocatechin-3-gallate onto the surface
of AuNPs, and confirmed the more effective inhibition of bladder
cancer in model mice. Thus, this review proposes FMN might work
as biocompatible nano-carrier for flavonoid delivery as well as
nano-drug to treat specific targeted diseases in single system.7. Conclusions and future perspective
Recently, there is a surge and focus of activity on preparation
and characterization of flavonoids based nanomaterials in various
capacities using the ‘Green’ synthesis. Detailed research is war-
ranted on mechanistic evaluation of the flavonoid-metal-
complexes in solution and in vivo. Modern research is now focused
on developing single molecule based nano-conjugates and some of
these formulations have promising potential in nanomedicine.
Overall it appears that even though there has been significant pro-
gress, a great deal can still be expected with the developments in
the field of nanoscience which may focus on single molecule based
nanomaterials such as bimetallic alloy nanoparticles which might
be more advantageous over ordinary MNPs. FMN to move into
the clinical arena, it is important that a systematic approach to test
the safety of nanoparticles, including the sub-lethal cellular
changes, should be foremostly established. Future work would be
focused on FMN designed for oral administration, superior gas-
trointestinal stability, mucus penetrating function, and intestinal
epithelial cell targeting properties.
Acknowledgments
The authors are grateful for the financial support from the
National Natural Science Foundation of China (21273081,
21673085, 61405062, and 61675071), the Guangdong Provincial
Department of Science and Technology (2013B051000074), the
Pearl River Nova Program of Guangzhou (201710010010), Joint
International Research Laboratory of Optical Information, and the
Key Laboratory of Optoelectronic Devices and Systems of Ministry
of Education and Guangdong Province (Shenzhen University).
References
[1] S.P. Chandran, M. Chaudhary, R. Pasricha, A. Ahmad, M. Sastry, Synthesis of
gold nanotriangles and silver nanoparticles using Aloe vera plant extract,
Biotechnol. Prog. 22 (2006) 577–583.
[2] J.M. Allen, J. Xu, M. Blahove, S.A. Canonico-May, T.J. Santaloci, M.E. Braselton,
M. Blahove, J.W. Stone, Synthesis of less toxic gold nanorods by using
dodecylethyldimethylammonium bromide as an alternative growth-directing
surfactant, J. Colloid Interf. Sci. 505 (2017) 1172–1176.
[3] L. Biao, S. Tan, Y. Wang, X. Guo, Y. Fu, F. Xu, Y. Zu, Z. Liu, Synthesis,
characterization and antibacterial study on the chitosan-functionalized Ag
nanoparticles, Mater. Sci. Eng. C 76 (2017) 73–80.
[4] M. Karimi, M.R. Ramsheh, S.M. Ahmadi, M.R. Madani, M. Shamsi, R. Reshadi, F.
Lotfi, Reline-assisted green and facile synthesis of fluorapatite nanoparticles,
Mater. Sci. Eng. C 77 (2017) 121–128.
30 P. Sathishkumar et al. /Materials Letters 210 (2018) 26–30[5] P. Sathishkumar, J. Preethi, R. Vijayan, A.R. Mohd Yusoff, F. Ameen, S. Suresh, R.
Balagurunathan, T. Palvannan, Anti-acne, anti-dandruff and anti-breast cancer
efficacy of green synthesised silver nanoparticles using Coriandrum sativum
leaf extract, J. Photochem. Photobiol. B 163 (2016) 69–76.
[6] X. Ye, L. Chen, L. Liu, Y. Bai, Electrochemical synthesis of selenium
nanoparticles and formation of sea urchin-like selenium nanoparticles by
electrostatic assembly, Mater. Lett. 196 (2017) 381–384.
[7] C.K. Venil, P. Sathishkumar, M. Malathi, R. Usha, R. Jayakumar, A.R. Mohd
Yusoff, W. Azlina Ahmad, Synthesis of flexirubin-mediated silver nanoparticles
using Chryseobacterium artocarpi CECT 8497 and investigation of its anticancer
activity, Mater. Sci. Eng. C 59 (2016) 228–234.
[8] P. Kuppusamy, M.M. Yusoff, G.P. Maniam, N. Govindan, Biosynthesis of
metallic nanoparticles using plant derivatives and their new avenues in
pharmacological applications - an updated report, Saudi Pharm. J. 24 (2016)
473–484.
[9] D. Rehana, D. Mahendiran, R. Senthil, Kumar, A. Kalilur Rahiman, In vitro
antioxidant and antidiabetic activities of zinc oxide nanoparticles synthesized
using different plant extracts, Bioprocess. Biosyst. Eng. 40 (2017) 943–957.
[10] N.J. Reddy, D.N. Vali, M. Rani, S.S. Rani, Evaluation of antioxidant, antibacterial
and cytotoxic effects of green synthesized silver nanoparticles by Piper longum
fruit, Mater. Sci. Eng. C 34 (2014) 115–122.
[11] B. Ahmad, N. Hafeez, S. Bashir, A. Rauf, M. Rehman, Phytofabricated gold
nanoparticles and their biomedical applications, Biomed. Pharmacother. 89
(2017) 414–425.
[12] M. Ovais, A. Raza, S. Naz, N.U. Islam, A.T. Khalil, S. Ali, M.A. Khan, Z.K. Shinwari,
Current state and prospects of the phytosynthesized colloidal gold
nanoparticles and their applications in cancer theranostics, Appl. Microbiol.
Biotechnol. 101 (2017) 3551–3565.
[13] N. Jayaprakash, J.J. Vijaya, K. Kaviyarasu, K. Kombaiah, L.J. Kennedy, R.J.
Ramalingam, M.A. Munusamy, H.A. Al-Lohedan, Green synthesis of Ag
nanoparticles using Tamarind fruit extract for the antibacterial studies, J.
Photochem. Photobiol. B 169 (2017) 178–185.
[14] B. Khodadadi, M. Bordbar, M. Nasrollahzadeh, Green synthesis of Pd
nanoparticles at Apricot kernel shell substrate using Salvia hydrangea
extract: Catalytic activity for reduction of organic dyes, J. Colloid Interf. Sci.
490 (2017) 1–10.
[15] P. Sathishkumar, K. Vennila, R. Jayakumar, A.R. Mohd Yusoff, T. Hadibarata, T.
Palvannan, Phyto-synthesis of silver nanoparticles using Alternanthera tenella
leaf extract: an effective inhibitor for the migration of human breast
adenocarcinoma (MCF-7) cells, Bioprocess Biosyst. Eng. 39 (2016) 651–659.
[16] G. Dehghan, Z. Khoshkam, Tin (II)-quercetin complex: synthesis, spectral
characterisation and antioxidant activity, Food Chem. 131 (2012) 422–426.
[17] S. Wang, J. Zhang, M. Chen, Y. Wang, Delivering flavonoids into solid tumors
using nanotechnologies, Expert Opin. Drug Deliv. 10 (2013) 1–18.
[18] N. Koirala, N.H. Thuan, G.P. Ghimire, D.V. Thang, J.K. Sohng, Methylation of
flavonoids: chemical structures, bioactivities, progress and perspectives for
biotechnological production, Enzyme Microb. Tech. 86 (2016) 103–116.
[19] M. Sghaier, I. Skandrani, N. Nasr, M.G. Franca, L. Chekir-Ghedira, K. Ghedira,
Flavonoids and sesquiterpenes from Tecurium ramosissimum promote
antiproliferation of human cancer cells and enhance antioxidant activity: a
structure-activity relationship study, Environ. Toxicol. Pharmacol. 32 (2011)
336–348.
[20] A. Martirosyan, K. Grintzalis, M. Polet, L. Laloux, Y.J. Schneider, Tuning the
inflammatory response to silver nanoparticles via quercetin in Caco-2 (co-
)cultures as model of the human intestinal mucosa, Toxicol. Lett. 253 (2016)
36–45.
[21] O. Zuas, N. Hamim, Y. Sampora, Bio-synthesis of silver nanoparticles using
water extract of Myrmecodia pendan (Sarang Semut plant), Mater. Lett. 123
(2014) 156–159.
[22] N. Muniyappan, N.S. Nagarajan, Green synthesis of silver nanoparticles with
Dalbergia spinosa leaves and their applications in biological and catalytic
activities, Process Biochem. 49 (2014) 1054–1061.
[23] D. Raghunandan, B. Ravishankar, G. Sharanbasava, D.B. Mahesh, V. Harsoor, M.
S. Yalagatti, M. Bhagawanraju, A. Venkataraman, Anti-cancer studies of noble
metal nanoparticles synthesized using different plant extracts, Cancer
Nanotechnol. 2 (2011) 57–65.
[24] S.A. Aromal, D. Philip, Green synthesis of gold nanoparticles using Trigonella
foenum-graecum and its size-dependent catalytic activity, Spectrochim. Acta A
Mol. Biomol. Spectrosc. 97 (2012) 1–5.
[25] K. Tahir, A. Ahmad, B. Li, A.U. Khan, S. Nazir, S. Khan, Z.U.H Khan, S.U. Khan,
Preparation, characterization and an efficient photocatalytic activity of Au/
TiO2 nanocomposite prepared by green deposition method, Mater. Lett. 178
(2016) 56–59.
[26] J. Kasthuri, S. Veerapandian, N. Rajendiran, Biological synthesis of silver and
gold nanoparticles using apiin as reducing agent, Colloid. Surface. B 68 (2009)
55–60.[27] J. Luo, J. Kong, B.Y. Dong, H. Huang, K. Wang, L.H. Wu, Y.Q. Chen, Baicalein
attenuates the quorum sensing-controlled virulence factors of Pseudomonas
aeruginosa and relieves the inflammatory response in P. aeruginosa-infected
macrophages by down regulating the MAPK and NFkB signal-transduction
pathways, Drug. Des. Devel. Ther. 10 (2016) 183–203.
[28] J. Rajkumari, S. Busi, A.C. Vasu, P. Reddy, Facile green synthesis of baicalein
fabricated gold nanoparticles and their antibiofilm activity against
Pseudomonas aeruginosa PAO1, Microb. Pathog. 107 (2017) 261–269.
[29] J.H. Gao, B.G. Liu, Z.X. Ning, R.X. Zhao, A.Y. Zhang, Q. Wu, Characterization and
antioxidant activity of flavonold-rich extracts from leaves of Ampelopsis
grossedentata, J. Food Biochem. 33 (2009) 808–820.
[30] G. Cao, E. Sofic, R.L. Prior, Antioxidant and prooxidant behavior of flavonoids:
structure-activity relationships, Free Rad. Biol. Med. 22 (1997) 749–760.
[31] Q. Guo, Q. Guo, J. Yuan, J. Zeng, Biosynthesis of gold nanoparticles using a kind
of flavonol: Dihydromyricetin, Colloids Surf. A 441 (2014) 127–132.
[32] C.Z. Radzikowski, J. Wietrzyk, G. Grynkiewicz, A. Opolski, Genisteina -
izoflawonoid soi o zró _znicowanym mechanizmie działania-implikacje
kliniczne w lecznictwie i prewencji chorób nowotworowych, Poste˛py Hig.
Med. Dos´w. 58 (2004) 128–139.
[33] E.U. Stolarczyk, K. Stolarczyk, M. Laszcz, M. Kubiszewski, W. Maruszak, W.
Olejarz, D. Bryk, Synthesis and characterization of genistein conjugated with
gold nanoparticles and the study of their cytotoxic properties, Eur. J. Pharm.
Sci. 1 (2017) 176–185.
[34] B.S. Raghavan, S. Kondath, R. Anantanarayanan, R. Rajaram, Kaempferol
mediated synthesis of gold nanoparticles and their cytotoxic effects on MCF-
7 cancer cell line, Process Biochem. 50 (2015) 1966–1976.
[35] D. Bagchi, M. Bagchi, S.J. Stohs, D.K. Das, S.D. Ray, C.A. Kuszynski, S.S. Joshi, H.G.
Pruess, Free radicals and grape seed proanthocyanidin extract: importance in
human health and disease prevention, Toxicology 148 (2000) 187.
[36] A. Vinodhini, K. Govindaraju, G. Singaravelu, A. Mohamed Sadiq, V. Ganesh
Kumar, Cardioprotective potential of biobased gold nanoparticles, Colloid.
Surface. B 1 (2014) 480–486.
[37] B. Kumar, Y. Angulo, K. Smita, L. Cumbal, A. Debut, Capuli cherry-mediated
green synthesis of silver nanoparticles under white solar and blue LED light,
Particuology 24 (2016) 123–128.
[38] A.F. Santos, D.F. Brotto, L.R. Favarin, N.A. Cabeza, G.R. Andrade, M. Batistote, A.
A. Cavalheiro, A. Neves, D. Rodrigues, A.D. Anjos, Study of the antimicrobial
activity of metal complexes and their ligands through bioassays applied to
plant extracts, Rev. Bras. Farmacogn. 24 (2014) 309–315.
[39] A.K. Mittal, S. Kumar, U.C. Banerjee, Quercetin and gallic acid mediated
synthesis of bimetallic (silver and selenium) nanoparticles and their antitumor
and antimicrobial potential, J. Colloid Interf. Sci. 431 (2014) 194–199.
[40] E. Halevas, C.M. Nday, A. Salifoglou, Hybrid catechin silica nanoparticle
influence on Cu(II) toxicity and morphological lesions in primary neuronal
cells, J. Inorg. Biochem. 163 (2016) 240–249.
[41] K. Satyavani, S. Gurudeeban, T. Ramanathan, T. Balasubramanian, Biomedical
potential of silver nanoparticles synthesized from calli cells of Citrullus
colocynthis (L.) Schrad, J. Nanobiotechnol. 9 (2011) 43–50.
[42] K. Rajaram, D.C. Aiswary, P. Sureshkumar, Green synthesis of silver
nanoparticle using Tephrosia tinctoria and its antidiabetic activity, Mater.
Lett. 138 (2015) 251–254.
[43] A.K. Mittal, D. Tripathy, A. Choudhary, P.K. Aili, A. Chatterjee, I.P. Singh, U.C.
Banerjee, Bio-synthesis of silver nanoparticles using Potentilla fulgens Wall.
exHook. and its therapeutic evaluation as anticancer and antimicrobial agent,
Mater. Sci. Eng. C 53 (2015) 120–127.
[44] G.M. Nazeruddin, N.R. Prasad, S.R. Prasad, Y.I. Shaikh, S.R. Waghmare, P.
Adhyapak, Coriandrum sativum seed extract assisted in situ green synthesis of
silver nanoparticle and its anti-microbial activity, Ind. Crops Prod. 60 (2014)
212–216.
[45] V.V. Makarov, A.J. Love, O.V. Sinitsyna, S.S. Makarova, I.V. Yaminsky, M.E.
Taliansky, N.O. Kalinina, ‘‘Green” nanotechnologies: synthesis of metal
nanoparticles using plants, Acta Nat. 6 (2014) 35–44.
[46] B. Kumar, K. Smita, L. Cumbal, A. Debut, Green synthesis of silver nanoparticles
using Andean blackberry fruit extract, Saudi J. Biol. Sci. 24 (2017) 45–50.
[47] J. Liang, H. Yan, P. Puligundla, X. Gao, Y. Zhou, X. Wan, Applications of chitosan
nanoparticles to enhance absorption and bioavailability of tea polyphenols: a
review, Food Hydrocolloid. 69 (2017) 286–292.
[48] Z. Li, H. Jiang, C. Xu, L. Gu, A review: Using nanoparticles to enhance absorption
and bioavailability of phenolic phytochemicals, Food Hydrocolloid. 43 (2015)
153–164.
[49] T. Zou, Z. Li, S.S. Percival, S. Bonard, L. Gu, Fabrication, characterization, and
cytotoxicity evaluation of cranberry procyanidins-zein nanoparticles, Food
Hydrocolloid. 27 (2012) 293–300.
[50] D.S. Hsieh, H. Wang, S.W. Tan, Y.H. Huang, C.Y. Tsai, M.K. Yeh, C.J. Wu, The
treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-
gold nanoparticles, Biomaterials 32 (2011) 7633–7640.
